glp-1 receptors in the brain Frontiers Lotte Bjerre Knudsen: The Scientist

Half-life of a drug is affected by several factors, including the drugs metabolism, its route of administration, and its affinity for certain tissues

Canadas drug agency recognises several of these liraglutide, naltrexone-bupropion, orlistat, and semaglutide as effective at producing clinically significant weight loss over at least a year

These therapies often come with premium pricing due to complex manufacturing processes, patent protections, and high R&D investments, making them inaccessible for many patients without robust insurance coverage

Existing weight-loss drugs such as Wegovy, commonly referred to a GLP-1s, mimic the effects of glucagon-like peptide-1, a hormone that regulates metabolism